Intuitive Corp (ISRG): Market Capitalization-to-Revenue Ratio

Symbol and logo of brand Intuitive Surgical Inc (ISRG)

Is it worth investing in Intuitive Surgical (ISRG), given the strict sanitary requirements for transporting medical technology? The historical P/S trend helps assess the risk of overpayment, and 13.20 expresses the current value of this metric. The business relies on the da Vinci system and the sale of consumables. A diversified warehouse network and component quality control guarantee assembly stability.

Price-to-Revenue Ratio: Intuitive (ISRG) for 07/04/2022 - 11/13/2026

Metric breakdowns and analytics for Intuitive Surgical Inc (ISRG)

- stock quotes and analyst forecast:
Price intuitive.com|ISRG - Price Target Chart
- stock exchange capitalization data:
Market Value Intuitive Surgical Inc|ISRG - Real Price to Acquire Entire Company
- book capitalization indicators:
Book Value per Share Intuitive Surgical|ISRG - Company Book Value|Market Cap to Net Assets Ratio intuitive.com|ISRG - Company Total Assets
- business debt structure and liquidity details:
Debt to Capital Intuitive Surgical|ISRG - Long-Term Debt to Equity|Short-Term Debt to Capital Ratio Intuitive Corp|ISRG - Company Total Debt|Debt to Book Capital Intuitive Surgical Inc|ISRG - Company Long-Term Debt|Short-Term Debt Volume Intuitive Surgical|Interim Coverage Ratio intuitive.com
- company profitability and valuation multiples indicators:
ISRG - Company Net Income|Net Profit Forecast Intuitive Surgical|ISRG - Price to Earnings Ratio|Market Cap to Future Earnings Ratio Intuitive Surgical, Inc.|ISRG - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Intuitive Surgical Inc|ISRG - Operating profit EBITDA|Net earnings per share for the last four quarters Intuitive Surgical|ISRG - Net earnings per share for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months intuitive.com|ISRG - Earnings growth in current year|Consensus forecast of earnings per share growth for next year Intuitive Surgical
- total revenue and sales volume data:
ISRG - Company Sales|Company Projected Revenue intuitive.com|ISRG - P/S Multiple|Market Cap to Future Revenue Ratio Intuitive Surgical Inc
Summary company analytics:intuitive.com
Mass-produced product of intuitive.com

Intuitive Surgical (ISRG) dominance in the robotic surgery segment via Da Vinci systems allows the market to price in a high premium for every unit of revenue generated. By analyzing the revenue multiple trend, an investor assesses the ratio of market capitalization to total sales, which enables the rapid identification of business overvaluation or hidden cash flow stagnation without waiting for quarterly reports.

Competitors of Intuitive Surgical

Market Cap to Sales Volume DHR|Price-to-Revenue Ratio Becton Dickinson BDX|Market Capitalization-to-Revenue Ratio STE|WST: Market Cap to Revenue|BAX - P/S Multiple|Masimo Corporation (MASI) - Price-to-Revenue Ratio|Market Cap to Revenue stevanatogroup.com|TFX (Teleflex) - P/S Multiple|Price to Sales Merit Medical Systems, Inc. MMSI|Price-to-Revenue Ratio Envista Holdings Corp (NVST)|ICU Medical Inc. - Market Cap to Revenue Ratio|DENTSPLY SIRONA Inc. - Market Cap to Revenue|Market Cap to Sales Volume LMAT (lemaitre.com)|ATRC - Price-to-Revenue Ratio|Price-to-Revenue Coefficient STAAR Surgical Co. STAA|NAGE: P/S Multiple|ZIMV - Price-to-Revenue Coefficient|Price-to-Revenue Ratio AngioDynamics, Inc.|Market Cap to Revenue Ratio CERS (cerus.com)|Market Cap to Revenue TKNO (Teknova)|Market Cap to Sales Volume MGRM|Sharps Technology - Market Cap to Revenue|P/S Multiple InfuSystem INFU|Utah Medical Products - P/S Multiple|Price-to-Revenue Coefficient KORU Medical Systems KRMD|NYXH (Nyxoah) - Market Cap to Revenue|MBOT: Market Cap to Sales Volume|PDEX (Pro-Dex Corp) - P/S Multiple|Zentek Corp (ZTEK) - Price-to-Revenue Coefficient|Market Cap to Revenue ELUT (Elutia Inc.)|Price-to-Revenue Ratio MLSS (milestonescientific.com)|P/S Multiple NXGL (NEXGEL)|Retractable Technologies Inc. (RVP) - Price to Sales|HBIO: Market Cap to Revenue|Market Capitalization-to-Revenue Ratio FEMY (Femasys Corporation)|meihuamed.com (MHUA) - Price-to-Revenue Ratio|POAI - Price-to-Revenue Coefficient|Market Cap to Revenue CJMB|P/S Multiple Atrion Corp.|Price-to-Revenue Ratio NeuroMetrix Corp (NURO)